The average of one year target price for Torrent Pharmaceuticals (NSEI:TORNTPHARM) has been revised up to 2,617.69/share. This is a 17.80% increase from the previous estimate of 2,222.21 on January 16, 2024.
The price target is an average of many targets provided by analysts. The latest targets range from a low of 1,545.30 to a high of 3,123.75 per share. The average price target represents a 0.34% increase from the last reported closing price of 2,608.85/share.
What is the feeling of the background?
There is 3 funds or institutions that report positions at Torrent Pharmacy. This is an increase of 1 owner or 50.00% in the last quarter. Average wallet weight of all funds dedicated to TORNTPHARM is 0.03%, an increase of 47.60%. The total shares owned by institutions increased by 53.64% in the last three months to 34,000 shares.
What are other shareholders doing?
NOEMX - Northern Emerging Markets Equity Index Fund holds 20,000 shares representing 0.01% ownership in the company. No changes in the last quarter.
MXENX โ Great-West Emerging Markets Equity Fund Institutional Class owns 12,000 shares representing 0.00% ownership in the company.
TEMUX - Emerging Markets Equity Fund owns 2,000 shares representing 0.00% ownership in the company. No changes in the last quarter.
Fintel is one of the most comprehensive investment research platforms available to individual investors, traders, financial advisors and small hedge funds.
Our data covers the globe and includes fundamentals, analyst reports, fund ownership and sentiment data, options sentiment, insider trading, options flows, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced quantitative models proven to enhance returns.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
